Ultra-rapid lispro improved postprandial glucose control compared to insulin lispro in predominantly Chinese patients with type 1 diabetes: A prospective, randomized, double-blind phase 3 study.

Jianhua Ma,Xiang Yan,Qiong Feng,Wei Liu,Federico Pérez Manghi,Pedro García-Hernández,Guixia Wang, Jianwei Xu,Yuan Yuan,Zhiguang Zhou

Diabetes, obesity & metabolism（2023）

引用 0|浏览2

暂无评分

摘要

In this study, URLi administered in a basal-bolus regimen demonstrated superiority to insulin lispro in controlling PPG excursions, with noninferiority of HbA1c control in predominantly Chinese patients with T1D.

查看译文

关键词

antidiabetic drug, clinical trial, insulin analogues, phase III study, type 1 diabetes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要